Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138125
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2005-08-29
Brief Title:
Fulvestrant andor Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Organization Data
Organization:
Translational Oncology Research International
Class:
OTHER
Study ID:
CDR0000439421
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Translational Oncology Research International
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of California Los Angeles | OTHER |
| Genentech Inc | INDUSTRY |
| AstraZeneca | INDUSTRY |